logo

Ryan Brown, MD

Ryan Brown, MD

Cardiology Walnut Creek, CA

Cardiovascular Consultants Medical Group, INC, Associate

Office Address

Office Map
  • 106 La Casa Via Ste 140
    Walnut Creek, CA 94598
    Phone: (925) 274-2860
    Fax: (925) 932-4527

Dr. Brown's Clinical Specialties & Interests

  • Cardiology: Interventional
  • Clinical Interests: Cardiovascular Diseases; Heart Catheterization

Dr. Brown's Faculty Appointments & Work History

  • PartnerCardiovascular Consultants Medical Grop
    Walnut Creek, CA
  • AssociateCardiovascular Consultants Medical Group
    Walnut Creek, CA
  • Attending PhysicianScripps Clinic
    La Jolla, CA

Dr. Brown's Education & Medical Training

  • Scripps ClinicScripps ClinicFellowship, Interventional Cardiology (IM)
  • UC Davis Medical CenterUC Davis Medical CenterFellowship, Cardiovascular Disease (IM)
  • Tulane Univ SOMTulane Univ SOMFellowship, Cardiovascular Disease (IM)
  • University of California at DavisUniversity of California at DavisResidency, Internal Medicine
  • University of California at DavisUniversity of California at DavisInternship, Internal Medicine
  • Northwestern Univ Med SchNorthwestern University Feinberg School of MedicineMedical School

Dr. Brown's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License2003 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine, 2005
  • American Board of Internal MedicineAmerican Board of Internal MedicineCardiovascular Disease, 2008
  • American Board of Internal MedicineAmerican Board of Internal MedicineInterventional Cardiology, 2009
  • Certification Board of Nuclear CardiologyCertification Board of Nuclear CardiologyNuclear Cardiology, 2009, Current

Dr. Brown's Awards, Honors, & Recognition

  • Phi Beta KappaMemberPhi Beta Kappa, 2007
  • University of California San DiegoB.S. Biology, Cum LaudeUniversity of California San Diego, 2007

Dr. Brown's Clinical Trials

Dr. Brown's Publications & Presentations

Journal Articles

  • Sex-Specific Outcomes Following Revascularization with Zotarolimus-eluting Stents: Comparison of angiographic and late-term angiographic outcomes.Brown R, Kandzari, Leon M, Catheterization and Cardiovascular Interventions
  • Clinical Outcomes Following Predilation with a Novel 1.25 mm Diameter Angioplasty Catheter.Kandzari D, Zankar, …. Brown R, Popma J., Catheterization and Cardiovascular Interventions
  • Over the speed limitRobinson,MR Brown, RA, Am J Medicine
  • Register to See 1 More...

Abstracts/Posters

  • Nocardial Epidural Abscess in a non-immunocompromised hospital.R. Brown, poster, American College of Physicians
  • The Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement Study (BAV-SAVR)Babaliaros V,.... R Brown, TCT, Washington, DC
  • Gender-Based Outcomes Following Treatment with Zotarolimus-Eluting stents: Analysis of 6 Clinical TrialsKandzari D, .. Brown, RA, ACC

Other

  • Letter to the Editor. Quality of life with PCI versus medical therapy in stable coronary diseaseBrown RA, Teirstein PS, Kandzari DE., New England Journal of Medicine

Research History

  • Sub-Investigator2009 - 2010
    PARTNER: Placement of Aortic Transcatheter Valve Trial
  • Sub-Investigator2009 - 2010
    PARTNER: Placement of Aortic Transcatheter Valve Trial
  • Sub-Investigator2008 - 2009
    A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm. The Medtronic RESOLUTE US Clinical Trial.
  • Sub-Investigator2008 - 2009
    SCRIPPS DES REAL WORLD REGISTRY: A Prospective Registry for the Use of Cypher™ Sirolimus-Eluting Stent in Patients with Coronary Artery Disease treated with Percutaneous Coronary Interventions at Scripps Clinic
  • Sub-Investigator2008 - 2009
    A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention. Protocol No. TMC-CAN-05-02. CHAMPION PCI.
  • Sub-Investigator2008 - 2009
    The effect of cangrelor on the pharmacodynamics of Clopidogrel. A clinical trial comparing cangrelor to Clopidogrel in subjects who require percutaneous coronary intervention. A substudy to Protocol No. TMC-CAN-05-02
  • Sub-Investigator2008 - 2009
    A Prospective, multi-center randomized controlled trial of the IMPELLA® RECOVER ® LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non-Emergent High Risk PCI. The PROTECT II Trial
  • Sub-Investigator2008 - 2009
    Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence. The CHOICE study
  • Sub-Investigator2008 - 2009
    Intracoronary Brachytherapy for Recurrent Restenosis after Multiple Drug-Eluting Stents. Short Title: SCRIPPS V
  • Sub-Investigator2008 - 2009
    Gauging Responsiveness with a VerifyNow Assay- Impact on Thrombosis and Safety: GRAVITAS
  • Sub-Investigator2008 - 2009
    Post-Market Observation Study of Intra-renal Drug Delivery. Short Title: The PROVIDE Study
  • Sub-Investigator2008 - 2009
    A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System for the Treatment of DeNovo Coronary Artery Lesions. The PERSEUS Trial
  • Sub-Investigator2008 - 2009
    A Prospective Evaluation in a non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS ® Element ™ Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo coronary Artery Lesions in Small Vessels. The PERSEUS Trial: Small Vessel
  • Sub-Investigator2008 - 2009
    Prospective, Multi-Center, Single-Blind, Two-Arm, Randomized Controlled Trial of the Conor Costar Paclitaxel-Eluting Coronary Stent System Versus the Taxus Drug-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries: Short Title: COSTAR II
  • Sub-Investigator2008 - 2009
    A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to two De Novo Coronary Artery Lesions. The PLATINUM Trial
  • Sub-Investigator2008 - 2009
    A Randomized, Double-Blind, Active- Controlled Trial to Evaluate Intravenous and Oral PRT060128, A Selective and Reversible P2Y12-Receptor Inhibitor, vs. Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent Percutaneous Coronary Interventions. The INNOVATE-PCI Study
  • Sub-Investigator2008 - 2009
    Maintenance of platelet inhibition with cangrelor after discontinuation of thienopyridines in patients undergoing surgery. The BRIDGE Study.
  • Sub-Investigator2008 - 2009
    A Phase II/III, Double-Blind, Randomized, Controlled, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s). The MARVEL Study
  • Sub-Investigator2008 - 2009
    A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients with Refractory Chronic Myocardial Ischemia (ACT 34-CMI).
  • Sub-Investigator2008 - 2009
    A 12-month follow up Study to Protocol No. 24779. A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients with Ref
  • Sub-Investigator2008 - 2009
    Human Recombinant Fibroblast Growth Factor-1 (FGF-1141) for the Treatment of Subjects with Severe Coronary Heart Disease, a Double-blind, Placebo-controlled, Dose-varying study. The FGF Study.
  • Sub-Investigator2008 - 2009
    PREDICT: Scripps Pilot Study on the Effect of High clopidogrel Maintenance Dosing and its Relationship to Cytochrome P450 2C19 Polymorphism Status [STSI/CTSA]
  • Sub-Investigator2008 - 2009
    An Unblinded, Multicenter, First-in-Man Imaging Study Comparing the REVO IQ System and Catheter with the Revolution and Atlantis IVUS Imaging Catheters in Subjects Scheduled for Stent Placement. The REVO-IQ Trial
  • Sub-Investigator2008 - 2009
    A randomized, un-blinded, multicenter Optical Coherence Tomography (OCT) imaging study in patients scheduled for either coronary diagnostic catheterization or intervention. The VOILA Trial.
  • Sub-Investigator2008 - 2009
    Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients: HOMEOSTASIS II
  • Sub-Investigator2008 - 2009
    SEASIDE: Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration with the Endeavor Stent
  • Sub-Investigator2008 - 2009
    A Multicenter, Randomized Study of the Sirolimus-Eluting Bx Velocity® Balloon- Expandable Stent vs Intravascular Brachytherapy in the Treatment of Patients with In-Stent Restenotic Coronary Artery Lesions. Short Title: The SISR Study
  • Sub-Investigator2008 - 2009
    A Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting Bx VelocityTM Balloon-Expandable Stent in the Treatment of Patients With DeNovo Native Coronary Artery Lesions (Protocol P03-6320) (SIRIUS 2.25mm)

Other Languages

  • Spanish

ACO/IPA Affiliations

  • John Muir Physician Network

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PowerSelect HMO
  • BCBS California PPO
  • Blue Shield CA Local Access Plus HMO
  • Blue Shield California HMO
  • Blue Shield California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • HealthAmerica HealthAssurance PPO
  • Highmark BCBS ClassicBlue
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Brown's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV